ask="7.30"
ask_size="100"
average_daily_volume="120173"
bid="4.38"
bid_size="1000"
book_value="1.98"
change="+0.28"
change_from_200_day_moving_average="0.19"
change_from_50_day_moving_average="0.68"
change_from_52_week_high="-3.74"
change_From_52_week_low="1.19"
change_in_percent="+6.78%"
close="4.41"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.14"
ex_dividend_date="N/A"
float_shares="8580000"
high="4.47"
high_52_weeks="8.15"
last_trade_date="1/10/2017"
last_trade_price="4.41"
last_trade_size="116"
last_trade_time="4:00pm"
low="4.01"
low_52_weeks="3.22"
market_capitalization="82.26M"
moving_average_200_day="4.22"
moving_average_50_day="3.73"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+4.58%"
percent_change_from_50_day_moving_average="+18.27%"
percent_change_from_52_week_high="-45.89%"
percent_change_from_52_week_low="+36.96%"
previous_close="4.13"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.09"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="2.34"
stock_exchange="NGM"
symbol="CATB"
volume="183134"
weeks_range_52="3.22 - 8.15"
